Gheewala, PA and Peterson, GM and Razi Zaidi, ST and Jose, MD and Castelino, RL, Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies, International journal of clinical pharmacy Article Epub ahead of print. ISSN 2210-7703 (2018) [Refereed Article]
Copyright 2018 Springer International Publishing AG, part of Springer Nature
Background: Patient satisfaction is an important determinant of the feasibility and sustainability of community pharmacy screening services. However, few studies have evaluated this, with no such study performed for a chronic kidney disease risk assessment service.
Objective: The aim was to determine patient satisfaction with a chronic kidney disease risk assessment service performed in community pharmacies.
Setting: Community pharmacies in the state of Tasmania, Australia.
Method: An anonymous nine-item satisfaction survey, with Likert-type scales, was developed following a literature review of existing surveys. Reliability of the nine-item scale was determined using Cronbach’s alpha. Patients were asked an additional question on willingness to pay, with choices of amount from $5 to $25. The satisfaction survey was mailed to 389 patients who participated in the chronic kidney disease risk assessment study.
Main outcome measure: Patient level of satisfaction with and willingness to pay for the chronic kidney disease service.
Results: Responses from 143 participants were included in the fnal analysis. Cronbach’s alpha for the nine-item satisfaction scale was 0.87. The majority of participants agreed that the time required to undergo the risk assessment process was justifed (90.2%); overall, they were satisfed with the chronic kidney disease risk assessment service (90.0%) and they felt comfortable with the pharmacist referring their results to their doctor (88.9%). Of 136 participants who answered the question on willingness to pay, 62.9% indicated that they would pay for the chronic kidney disease service. Of these, 29.2, 25.8 and 19.1% were willing to pay $20, $10 and $5, respectively.
Conclusion: Patient satisfaction with the community pharmacy-based chronic kidney disease risk assessment was high. These fndings provide support for the implementation of the service within community pharmacy practice.
|Item Type:||Refereed Article|
|Keywords:||kidney disease pharmacist|
|Research Division:||Medical and Health Sciences|
|Research Group:||Clinical Sciences|
|Research Field:||Nephrology and Urology|
|Objective Group:||Clinical Health (Organs, Diseases and Abnormal Conditions)|
|Objective Field:||Urogenital System and Disorders|
|Author:||Gheewala, PA (Miss Pankti Gheewala)|
|Author:||Peterson, GM (Professor Gregory Peterson)|
|Author:||Razi Zaidi, ST (Dr Tabish Razi Zaidi)|
|Author:||Jose, MD (Professor Matthew Jose)|
|Author:||Castelino, RL (Dr Ronald Castelino)|
|Deposited By:||Medicine (Discipline)|
Repository Staff Only: item control page